|
115
|
Safety Signal of Azithromycin and the Risk of Ventricular fibrillation
|
|
Signal
|
|
|
114
|
Safety Signal of Tioguanine and the Risk of Rash
|
|
Signal
|
|
|
113
|
Safety Signal of Tioguanine and the Risk of Arthralgia
|
|
Signal
|
|
|
112
|
Safety Signal of Omalizumab and the Risk of Blurred vision
|
|
Signal
|
|
|
110
|
Safety Signal of Sitagliptin and the Risk of Vertigo
|
|
Signal
|
|
|
109
|
Safety Signal of Atezolizumab and the Risk of Pericardial Effusion
|
|
Signal
|
|
|
103
|
Safety Signal of Aflibercept and the Risk of Fournier’s gangrene (updated)
|
|
Signal
|
|
|
111
|
Safety Signal of Azithromycin and the Risk of Cyanosis
|
|
Signal
|
|
|
110
|
Safety Signal of Clomifene and the Risk of Blindness
|
|
Signal
|
|
|
109
|
Safety Signal of Dulaglutide and the Risk of Diverticulitis
|
|
Signal
|
|
